Lymphoma
Dietary Intervention for Improvement of Side Effects Among DLBCL Survivors
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
Dietary Intervention for Improvement of Side Effects Among DLBCL Survivors
Risk of ALCL Following Postmastectomy Implant Reconstruction
ASH 2022: Re-evaluating the Standard of Care in Mantle Cell Lymphoma
NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas (Version 3.2022)
ASTRO 2022: A Novel Approach for Radiotherapy in Orbital Indolent B-Cell Lymphoma
Anaplastic Large-Cell Lymphoma of the Breast: Incidence in the United States
Trends in Improvements in Survival Among Patients With DLBCL
Trends in Cutaneous T-Cell Lymphoma Incidence in the United States
Real-World Outcomes With Axicabtagene Ciloleucel Therapy for Large B-Cell Lymphoma
Characteristics of Advanced Extranodal Natural Killer/ T-Cell Lymphoma and its Treatment
Results From Large Real-World Cohorts on Treatment Outcomes in Patients With Mantle Cell Lymphoma
ASCO 2022: Ibrutinib Added to Bendamustine/Rituximab for Older Patients With Mantle Cell Lymphoma
CAR T-Cell Therapy: Rates of Rehospitalization and Emergency Department Visits Postinfusion
Innate Cell Engager AFM13 Plus Natural Killer Cells for Lymphoma
Immune Responses Among Patients With B-Cell Malignancies Post–COVID-19 Vaccination
Polatuzumab Vedotin-piiq Plus R-CHP vs R-CHOP in Previously Untreated DLBCL: POLARIX Trial
Using PET Scans to Direct Therapy Decisions in Advanced Hodgkin Lymphoma
Mosunetuzumab for Relapsed or Refractory Aggressive and Indolent B-Cell Non-Hodgkin Lymphomas
Emerging Therapies and Current Unmet Needs for Patients With Relapsed or Refractory DLBCL